Ligne de temps

Philippe Souque
Ingénieur(e) de Recherche
01 janv. 2023
publication
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.
Lire plus14 sept. 2022
publication
A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.
Lire plus26 juil. 2022
publication
A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity.
Lire plus07 déc. 2021
publication
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Lire plus04 janv. 2021
publication
Clustering and reverse transcription of HIV-1 genomes in nuclear niches of macrophages.
Lire plus01 janv. 2021
publication
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.
Lire plus16 déc. 2020
publication
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Lire plus02 sept. 2020
publication
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Lire plus01 sept. 2020
publication